Skip to main content

Diabetes KOS Argus Continuing Glucose Monitoring System

Status: Coming Soon

Study details

View study details on clinicaltrials.gov.

Locations

  • Burlingame

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Argus 2.0 Adoption Study

David Klonoff, M.D.
David Klonoff, M.D.
Principal investigator
View profile

Related clinical trials

View all clinical trials
  • GENESIS: next GENEration Sensor Life Study

    Status: Open to Enrollment

  • GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

    Status: Open to Enrollment

  • A Double-Blinded, Placebo-controlled, Double Dummy, Multi-center Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on One to Three Glucose-lowering Agents

    Status: Coming Soon

  • A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Once-Daily Oral Orforglipron Compared With Once-Weekly Dulaglutide in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes

    Status: Coming Soon

  • A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

    Status: Open to Enrollment

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?